Email this article to a friend
A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care
-
* Corresponding author: Christopher J Longo cjlongo@mcmaster.ca
Critical Care 2007, 11:R128 doi:10.1186/cc6195
See related commentary by Erickson and Martin., http://ccforum.com/content/12/1/109